Dr. Kim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Dept Dermatology, Perelman School of Medicine at Univ Pennsylvania
3400 Civic Center Blvd
Philadelphia, PA 19104Phone+1 215-662-2737Fax+1 215-615-4966- Is this information wrong?
Summary
- Dr. Ellen J. Kim is a board certified dermatologist and Professor of Dermatology at the Perelman School of Medicine at the University of Pennsylvania. She is currently the Director of the Penn Cutaneous Lymphoma Program/Photopheresis Service and Vice Chair of Clinical Operations for the Department of Dermatology. She is an international expert in the diagnosis and multidisciplinary clinical care of patients with cutaneous lymphomas and the use of extracorporeal photopheresis. Her primary research focus is clinical trials of novel therapies for cutaneous T-cell lymphoma (CTCL).
Education & Training
- Boston University Medical CenterResidency, Dermatology, 1997 - 2000
- Perelman School of Medicine at the University of PennsylvaniaClass of 1996
Certifications & Licensure
- NJ State Medical License 2022 - 2025
- PA State Medical License 2002 - 2024
- MA State Medical License 1998 - 2003
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Leonard Berwick Memorial Teaching Award Perelman School of Medicine at the University of Pennsylvania, 2014
- Inaugural Class, The Academy of Master Clinicians Penn Medicine, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Clinical Trials
- Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL Start of enrollment: 2012 Nov 01
Publications & Presentations
PubMed
- Chronic Graft-versus-Host Disease-Associated Muscle Cramps: Severity and Response to Immunomodulatory Therapies.Supriya Rastogi, Ellen J Kim, Joel M Gelfand, Alison W Loren, Emily Baumrin> ;Transplantation and Cellular Therapy. 2024 Mar 1
- 1 citationsFour cases of cutaneous Rosai-Dorfman in Black patients: A review of a single institution's experience with this rare disease.Banbury, S., Chu, B., Hedberg, M., Ogunleye, T., Kim, E., Rosenbach, M.> ;JAAD Case Reports. 2023 Dec 1
- Changes to Registered and Pivotal Clinical Trials after the 2011 Tri-Societies Guidelines for Clinical Endpoints and Response Criteria in Mycosis Fungoides and Sézary ...Simon J Gunter, Ellen J Kim> ;The Journal of Investigative Dermatology. 2024 Apr 1
- Join now to see all
Journal Articles
- Brentuximab Vedotin for Relapsed or Refractory Sézary SyndromePaul L Haun, Sara S Samimi, Alain H Rook, Ellen J Kim, JAMA Dermatology
- Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary SyndromeEllen J Kim, Carmela Vittorio, Paul L Haun, Sara S Samimi, Rachael A Clark, Alain H Rook, JAMA Dermatology
Press Mentions
- HyBryte™ Phase 3 FLASH Study for the Treatment of Cutaneous T-cell Lymphoma Published in JAMA DermatologyJuly 20th, 2022
- Soligenix Corporate Update Letter - Key Highlights and Upcoming CatalystsJanuary 10th, 2022
- Soligenix: Phase III Trial Success Offers New Hope to Those Living with Rare DiseaseAugust 12th, 2021
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
- Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania
- Penn Presbyterian Medical CenterPhiladelphia, Pennsylvania
- Pennsylvania HospitalPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: